Donal O'Connor's Insider Trades & SAST Disclosures
Donal O'Connor's most recent trade in Perrigo Company plc was a trade of 9,904 Restricted Stock Units done . Disclosure was reported to the exchange on May 14, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Donal O'Connor.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Perrigo Company plc | Donal O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 9,904 | 9,904 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Donal O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2024 | 8,764 | 0 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Donal O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.22 per share. | 14 May 2024 | 8,764 | 29,694 (0%) | 0% | 30.2 | 264,848 | Ordinary Shares |
| Perrigo Company plc | Donal O'Connor | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.22 per share. | 14 May 2024 | 4,207 | 25,487 (0%) | 0% | 30.2 | 127,136 | Ordinary Shares |
| Theravance Biopharma Inc | Donal O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 23,576 | 23,576 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Donal O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 10,537 | 63,555 (0%) | 0% | 0 | Ordinary Shares | |
| Perrigo Company plc | Donal O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 7,778 | 0 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Donal O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.86 per share. | 17 May 2023 | 7,778 | 24,664 (0%) | 0% | 32.9 | 255,585 | Ordinary Shares |
| Perrigo Company plc | Donal O'Connor | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.86 per share. | 17 May 2023 | 3,734 | 20,930 (0%) | 0% | 32.9 | 122,699 | Ordinary Shares |
| Perrigo Company plc | Donal O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 8,764 | 8,764 | - | - | Restricted Stock Units | |
| Theravance Biopharma Inc | Donal O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 22,044 | 22,044 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Donal O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 9,132 | 53,018 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Donal O'Connor | Director | Sale or transfer of securities back to the company at price $ 10.50 per share. | 22 Nov 2022 | 10,000 | 43,886 (0%) | 0% | 10.5 | 105,000 | Ordinary Shares |
| Perrigo Company plc | Donal O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 7,778 | 7,778 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Donal O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2022 | 6,599 | 0 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Donal O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.57 per share. | 17 May 2022 | 6,599 | 20,054 (0%) | 0% | 38.6 | 254,523 | Ordinary Shares |
| Perrigo Company plc | Donal O'Connor | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.57 per share. | 17 May 2022 | 3,168 | 16,886 (0%) | 0% | 38.6 | 122,190 | Ordinary Shares |
| Theravance Biopharma Inc | Donal O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 28,000 | 28,000 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Donal O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 9,852 | 53,886 (0%) | 0% | 0 | Ordinary Shares | |
| Perrigo Company plc | Donal O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 6,599 | 6,599 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Donal O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2021 | 5,804 | 0 | - | - | Restricted Stock Units | |
| Perrigo Company plc | Donal O'Connor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.96 per share. | 07 May 2021 | 5,804 | 16,241 (0%) | 0% | 43.0 | 249,340 | Ordinary Shares |
| Perrigo Company plc | Donal O'Connor | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.96 per share. | 07 May 2021 | 2,786 | 13,455 (0%) | 0% | 43.0 | 119,687 | Ordinary Shares |
| Theravance Biopharma Inc | Donal O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 9,828 | 44,034 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Donal O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 6,000 | 6,000 | - | - | Share Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges